A notable variation in RAB39 expression was observed among 26 cancer types (Figure 1a), including AML (LAML), when comparing the expression of RAB39B in normal and tumor samples from TCGA and GTEx databases (Figure 1b). The gene discussed is RAB39B; the disease is acute myeloid leukemia.